INCYTE CORPORATION Stock-Based Compensation
INCYTE CORPORATION (INCY) reported Stock-Based Compensation of $64.13 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-04-28
- INCYTE CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $64.13M, a 5.16% increase year-over-year.
- INCYTE CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $62.16M, a 13.33% decline year-over-year.
- INCYTE CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $61.60M, a 20.95% decline year-over-year.
- INCYTE CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $64.61M, a 14.07% increase year-over-year.
- INCYTE CORPORATION share-based payment arrangement, noncash expense for fiscal 2025 was $249.35M, a 6.28% decline from fiscal 2024.
- INCYTE CORPORATION share-based payment arrangement, noncash expense for fiscal 2024 was $266.06M, a 23.24% increase from fiscal 2023.
- INCYTE CORPORATION share-based payment arrangement, noncash expense for fiscal 2023 was $215.89M, a 14.58% increase from fiscal 2022.
- INCYTE CORPORATION share-based payment arrangement, noncash expense for fiscal 2022 was $188.42M, a 2.96% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-03-31 | $64.13M 10-Q · filed 2026-04-28 | $126.28M derived: sum of 2 quarters · filed 2026-04-28 | $187.88M derived: sum of 3 quarters · filed 2026-04-28 | $252.49M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | $62.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $123.75M derived: sum of 2 quarters · filed 2026-02-10 | $188.36M derived: sum of 3 quarters · filed 2026-02-10 | $249.35M 10-K · filed 2026-02-10 |
| 2025-09-30 | $61.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $126.21M derived: sum of 2 quarters · filed 2025-10-28 | $187.19M 10-Q · filed 2025-10-28 | $258.91M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-06-30 | $64.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $125.59M 10-Q · filed 2025-07-29 | $197.31M derived: sum of 3 quarters · filed 2026-04-28 | $275.23M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-03-31 | $60.98M 10-Q · filed 2026-04-28 | $132.70M derived: sum of 2 quarters · filed 2026-04-28 | $210.62M derived: sum of 3 quarters · filed 2026-04-28 | $267.26M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $71.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $149.64M derived: sum of 2 quarters · filed 2026-02-10 | $206.28M derived: sum of 3 quarters · filed 2026-02-10 | $266.06M 10-K · filed 2026-02-10 |
| 2024-09-30 | $77.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $134.56M derived: sum of 2 quarters · filed 2025-10-28 | $194.34M 10-Q · filed 2025-10-28 | $254.33M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $56.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $116.42M 10-Q · filed 2025-07-29 | $176.41M derived: sum of 3 quarters · filed 2026-02-10 | $224.41M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $59.78M 10-Q · filed 2025-04-29 | $119.77M derived: sum of 2 quarters · filed 2026-02-10 | $167.77M derived: sum of 3 quarters · filed 2026-02-10 | $222.29M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $59.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $107.99M derived: sum of 2 quarters · filed 2026-02-10 | $162.51M derived: sum of 3 quarters · filed 2026-02-10 | $215.89M 10-K · filed 2026-02-10 |
| 2023-09-30 | $48.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $102.52M derived: sum of 2 quarters · filed 2024-10-29 | $155.90M 10-Q · filed 2024-10-29 | $208.58M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $54.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $107.90M 10-Q · filed 2024-07-30 | $160.58M derived: sum of 3 quarters · filed 2025-02-10 | $205.98M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | $53.38M 10-Q · filed 2024-04-30 | $106.06M derived: sum of 2 quarters · filed 2025-02-10 | $151.46M derived: sum of 3 quarters · filed 2025-02-10 | $197.96M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | $52.68M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $98.08M derived: sum of 2 quarters · filed 2025-02-10 | $144.58M derived: sum of 3 quarters · filed 2025-02-10 | $188.42M 10-K · filed 2025-02-10 |
| 2022-09-30 | $45.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $91.90M derived: sum of 2 quarters · filed 2023-10-31 | $135.74M 10-Q · filed 2023-10-31 | $183.96M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $46.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $90.34M 10-Q · filed 2023-08-01 | $138.56M derived: sum of 3 quarters · filed 2024-02-13 | $181.25M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $43.84M 10-Q · filed 2023-05-02 | $92.06M derived: sum of 2 quarters · filed 2024-02-13 | $134.76M derived: sum of 3 quarters · filed 2024-02-13 | $179.49M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $48.22M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $90.92M derived: sum of 2 quarters · filed 2024-02-13 | $135.65M derived: sum of 3 quarters · filed 2024-02-13 | $183.01M 10-K · filed 2024-02-13 |
| 2021-09-30 | $42.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $87.43M derived: sum of 2 quarters · filed 2022-11-01 | $134.78M 10-Q · filed 2022-11-01 | $180.04M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | $44.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $92.09M 10-Q · filed 2022-08-02 | $137.35M derived: sum of 3 quarters · filed 2023-02-07 | $181.15M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | $47.36M 10-Q · filed 2022-05-03 | $92.62M derived: sum of 2 quarters · filed 2023-02-07 | $136.42M derived: sum of 3 quarters · filed 2023-02-07 | $182.72M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | $45.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $89.06M derived: sum of 2 quarters · filed 2023-02-07 | $135.36M derived: sum of 3 quarters · filed 2023-02-07 | $177.88M 10-K · filed 2023-02-07 |
| 2020-09-30 | $43.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $90.10M derived: sum of 2 quarters · filed 2021-11-02 | $132.62M 10-Q · filed 2021-11-02 | $174.64M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-06-30 | $46.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $88.82M 10-Q · filed 2021-08-03 | $130.84M derived: sum of 3 quarters · filed 2022-02-08 | $174.20M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-03-31 | $42.51M 10-Q · filed 2021-05-04 | $84.54M derived: sum of 2 quarters · filed 2022-02-08 | $127.89M derived: sum of 3 quarters · filed 2022-02-08 | $168.51M derived: sum of 4 quarters · filed 2022-02-08 |
| 2019-12-31 | $42.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $85.38M derived: sum of 2 quarters · filed 2022-02-08 | $126.00M derived: sum of 3 quarters · filed 2022-02-08 | $166.59M 10-K · filed 2022-02-08 |
| 2019-09-30 | $43.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $83.97M derived: sum of 2 quarters · filed 2020-11-05 | $124.57M 10-Q · filed 2020-11-05 | $161.89M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $40.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $81.21M 10-Q · filed 2020-08-04 | $118.53M derived: sum of 3 quarters · filed 2021-02-09 | $156.53M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | $40.59M 10-Q · filed 2020-05-05 | $77.92M derived: sum of 2 quarters · filed 2021-02-09 | $115.92M derived: sum of 3 quarters · filed 2021-02-09 | $152.52M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | $37.32M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $75.32M derived: sum of 2 quarters · filed 2021-02-09 | $111.93M derived: sum of 3 quarters · filed 2021-02-09 | $148.15M 10-K · filed 2021-02-09 |
| 2018-09-30 | $38.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $74.61M derived: sum of 2 quarters · filed 2019-10-29 | $110.83M 10-Q · filed 2019-10-29 | $144.60M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $36.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $72.83M 10-Q · filed 2019-07-30 | $106.60M derived: sum of 3 quarters · filed 2020-02-13 | $141.53M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $36.22M 10-Q · filed 2019-04-30 | $69.99M derived: sum of 2 quarters · filed 2020-02-13 | $104.92M derived: sum of 3 quarters · filed 2020-02-13 | $138.67M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $33.77M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $68.70M derived: sum of 2 quarters · filed 2020-02-13 | $102.44M derived: sum of 3 quarters · filed 2020-02-13 | $133.06M 10-K · filed 2020-02-13 |
| 2017-09-30 | $34.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $68.67M derived: sum of 2 quarters · filed 2018-10-30 | $99.29M 10-Q · filed 2018-10-30 | $126.89M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | $33.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $64.36M 10-Q · filed 2018-07-31 | $91.96M derived: sum of 3 quarters · filed 2019-02-14 | $118.49M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | $30.61M 10-Q · filed 2018-05-01 | $58.22M derived: sum of 2 quarters · filed 2019-02-14 | $84.74M derived: sum of 3 quarters · filed 2019-02-14 | $106.05M derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | $27.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $54.13M derived: sum of 2 quarters · filed 2019-02-14 | $75.43M derived: sum of 3 quarters · filed 2019-02-14 | $96.20M 10-K · filed 2019-02-14 |
| 2016-09-30 | $26.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $47.83M derived: sum of 2 quarters · filed 2017-10-31 | $68.60M 10-Q · filed 2017-10-31 | $85.69M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-06-30 | $21.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $42.07M 10-Q · filed 2017-08-01 | $59.17M derived: sum of 3 quarters · filed 2018-02-15 | $76.79M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-03-31 | $20.77M 10-Q · filed 2017-05-04 | $37.87M derived: sum of 2 quarters · filed 2018-02-15 | $55.49M derived: sum of 3 quarters · filed 2018-02-15 | $73.08M derived: sum of 4 quarters · filed 2018-02-15 |
| 2015-12-31 | $17.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $34.72M derived: sum of 2 quarters · filed 2018-02-15 | $52.31M derived: sum of 3 quarters · filed 2018-02-15 | $69.87M 10-K · filed 2018-02-15 |
| 2015-09-30 | $17.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $35.22M derived: sum of 2 quarters · filed 2016-11-01 | $52.77M 10-Q · filed 2016-11-01 | $68.68M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $17.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $35.15M 10-Q · filed 2016-08-09 | $51.05M derived: sum of 3 quarters · filed 2017-02-14 | $66.48M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | $17.56M 10-Q · filed 2016-05-09 | $33.46M derived: sum of 2 quarters · filed 2017-02-14 | $48.89M derived: sum of 3 quarters · filed 2017-02-14 | $64.37M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | $15.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $31.33M derived: sum of 2 quarters · filed 2017-02-14 | $46.81M derived: sum of 3 quarters · filed 2017-02-14 | $62.16M 10-K · filed 2017-02-14 |
| 2014-09-30 | $15.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $30.91M derived: sum of 2 quarters · filed 2015-11-03 | $46.25M 10-Q · filed 2015-11-03 | $56.07M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | $15.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $30.82M 10-Q · filed 2015-08-04 | $40.65M derived: sum of 3 quarters · filed 2016-02-12 | $50.09M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | $15.35M 10-Q · filed 2015-04-30 | $25.17M derived: sum of 2 quarters · filed 2016-02-12 | $34.62M derived: sum of 3 quarters · filed 2016-02-12 | $44.55M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | $9.82M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $19.27M derived: sum of 2 quarters · filed 2016-02-12 | $29.20M derived: sum of 3 quarters · filed 2016-02-12 | $38.40M 10-K · filed 2016-02-12 |
| 2013-09-30 | $9.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $19.38M derived: sum of 2 quarters · filed 2014-10-30 | $28.58M 10-Q · filed 2014-10-30 | $37.64M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | $9.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $19.13M 10-Q · filed 2014-07-31 | $28.20M derived: sum of 3 quarters · filed 2015-02-17 | $37.78M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | $9.20M 10-Q · filed 2014-05-01 | $18.26M derived: sum of 2 quarters · filed 2015-02-17 | $27.85M derived: sum of 3 quarters · filed 2015-02-17 | $37.76M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $9.07M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $18.65M derived: sum of 2 quarters · filed 2015-02-17 | $28.56M derived: sum of 3 quarters · filed 2015-02-17 | $38.49M 10-K · filed 2015-02-17 |
| 2012-09-30 | $9.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $19.49M derived: sum of 2 quarters · filed 2013-10-31 | $29.43M 10-Q · filed 2013-10-31 | $36.87M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-06-30 | $9.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $19.84M 10-Q · filed 2013-08-01 | $27.29M derived: sum of 3 quarters · filed 2014-02-21 | $34.69M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-03-31 | $9.93M 10-Q · filed 2013-05-02 | $17.38M derived: sum of 2 quarters · filed 2014-02-21 | $24.78M derived: sum of 3 quarters · filed 2014-02-21 | $31.97M derived: sum of 4 quarters · filed 2014-02-21 |
| 2011-12-31 | $7.45M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $14.85M derived: sum of 2 quarters · filed 2014-02-21 | $22.04M derived: sum of 3 quarters · filed 2014-02-21 | $28.98M 10-K · filed 2014-02-21 |
| 2011-09-30 | $7.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $14.59M derived: sum of 2 quarters · filed 2012-11-01 | $21.54M 10-Q · filed 2012-11-01 | $25.66M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-06-30 | $7.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $14.14M 10-Q · filed 2012-08-03 | $18.26M derived: sum of 3 quarters · filed 2013-02-21 | $22.32M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-03-31 | $6.95M 10-Q · filed 2012-04-26 | $11.07M derived: sum of 2 quarters · filed 2013-02-21 | $15.13M derived: sum of 3 quarters · filed 2013-02-21 | $18.68M derived: sum of 4 quarters · filed 2013-02-21 |
| 2010-12-31 | $4.12M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $8.18M derived: sum of 2 quarters · filed 2013-02-21 | $11.73M derived: sum of 3 quarters · filed 2013-02-21 | $14.86M 10-K · filed 2013-02-21 |
| 2010-09-30 | $4.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | $7.61M derived: sum of 2 quarters · filed 2011-10-27 | $10.73M 10-Q · filed 2011-10-27 | |
| 2010-06-30 | $3.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $6.68M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $3.12M 10-Q · filed 2011-05-03 | |||
| 2009-12-31 | $9.98M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |